Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Treatment of dermatophyte infection in our country (Pakistan) is becoming difficult due to the developing resistance to traditional antifungal agents. Assessing the effectiveness ,feasibility and standard dosage of a newer antifungal drug like voriconazole is the need of the hour in resistant cases of dermatophyte infection.
Epistemonikos ID: 0759e0190d949729e373db30bb4505dd9234041a
First added on: Dec 01, 2024